← Back to Clinical Trials
Recruiting NCT06077942

FX Shoulder Solutions Retrospective / Prospective Clinical Study

Trial Parameters

Condition Rotator Cuff Syndrome of Shoulder and Allied Disorders
Sponsor FX Shoulder Solutions
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-12-06
Completion 2032-12-30
Interventions
FX Artificial Shoulder Prosthesis

Brief Summary

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

Eligibility Criteria

Inclusion Criteria: * Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023. Exclusion Criteria: * Patient who does not meet the inclusion criteria above

Related Trials